Form 4: Fortive Corp Director Kate Mitchell Reports Stock and Option Grants

Director Kate Mitchell reports the acquisition of Fortive Corp stock and stock options on June 3, 2024, through restricted stock units and a director stock option grant.

Summary

• On June 3, 2024, Kate Mitchell, a director of Fortive Corp, reported the acquisition of 1,970 shares of common stock through restricted stock units (Annual Grant RSUs).
• These RSUs were granted as part of the annual equity grant and vest on the earlier of June 3, 2025, or the date of the Issuer's 2025 annual meeting of the stockholders.
• Mitchell also acquired 985 shares of common stock through restricted stock units (Deferral RSUs) based on a 20-day average price of $76.14, pursuant to a deferral election of $75,000 in annual retainer.
• These Deferral RSUs vest on the earlier of June 3, 2025, or the date of the Issuer's 2025 annual meeting of the stockholders, with shares issued upon death or retirement.
• Additionally, Mitchell acquired a director stock option (right to buy) for 1,990 shares of common stock at an exercise price of $72.95, exercisable from June 3, 2024, and expiring on June 3, 2034.
• Following these transactions, Mitchell beneficially owns 27,832 shares of common stock and 1,990 director stock options.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the document primarily reports routine stock and option grants to a director, which is a common practice. There are no explicit positive or negative implications for the company's performance.

Positives

• The grant of restricted stock units and stock options to a director aligns their interests with those of the shareholders.
• The deferral of cash compensation into stock demonstrates a long-term commitment to the company's success.

Future Outlook

The Annual Grant RSUs vest on the earlier of the first anniversary of the grant date or the date of the Issuer's 2025 annual meeting of the stockholders, with the underlying shares to be delivered upon vesting. The Deferral RSUs vest on the earlier of the first anniversary of the grant date or the date of the Issuer's 2025 annual meeting of the stockholders, but the underlying shares will not be issued until the earlier of the Reporting Person's death or the first day of the seventh month following the Reporting Person's retirement from the Board of Directors of the Issuer.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to monitor the actions of those with privileged information.

Comparison to Industry Standards

• Executive compensation packages often include a mix of salary, stock options, and restricted stock units to align management's interests with shareholder value.
• The vesting schedules and terms of these grants are generally consistent with industry practices for executive compensation.
• Comparing Fortive's executive compensation structure with peers like Danaher or Agilent Technologies would provide further context.

Stakeholder Impact

• The transactions reported in this Form 4 filing may influence investor perception of the company's stock.
• The grants of equity to directors can align their interests with those of shareholders, potentially leading to better corporate governance and decision-making.

Key Dates